Hints and tips:
Related Special Reports
...If enacted, the bill will have far-reaching consequences for the US pharmaceutical industry....
...Along with striking a co-brand deal with CVS to offer Hyrimoz at a discounted price of $1,315 a month, Sandoz has a higher list price version of the biosimilar, priced similarly to Humira at more than $6,000...
...It is a similar milestone-based structure to many partnerships in the pharmaceutical industry....
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
...the first pharmaceutical treatment for the underlying disease,” said Emmick....
US healthcare company is putting cash to work from spinning off its consumer health arm
...The US pharmaceutical company — whose shares are up 130 per cent over the past year and is now a top-10 S&P 500 stock — chose the week of the Oscars to launch an advert called “Big Night”....
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against pharmacies such as CVS and Walgreens....
...therapies based on Crispr gene-editing globally is “unrealistic” and the sector needs heavy investment to make the technology, which could transform treatment of diseases, accessible to all, according to its co-discoverer...
...The company has been working with the pharmaceutical giant GSK, focusing on immuno-oncology drugs....
...The results will renew attention on the possible effectiveness of lixisenatide, which is made by French pharmaceutical group Sanofi, and other so-called GLP-1 drugs against neurodegenerative conditions....
Breakthrough medicine will now be subject to further review by committee of independent experts
...But the proposal has run into opposition from the pharmaceutical industry....
...“We aim to not just alleviate disease symptoms, but to address the root causes of heart failure and restore the normal functioning of the heart,” said Thomas Thum, Cardior’s co-founder....
...Many biotechs hoping to enter the market will aim for partnerships with larger groups, a well-trodden path in the pharmaceutical industry....
...Eli Lilly was once considered something of an also-ran in the pharmaceutical industry....
...Pharmaceutical companies must replenish their drugs pipeline before exclusivity rights on top-selling products expire....
...Eli Lilly is racing to secure the services of outsourcers to boost production of its obesity drug Zepbound, as the US pharmaceutical group rolls out its rival to Danish group Novo Nordisk’s blockbuster appetite...
...Orchard, a UK-based biotech that was recently bought by Japanese pharmaceutical group Kyowa Kirin, argued that the lack of other treatments for MLD justified the price....
...“The presence of interferon-γ could be used to diagnose long Covid in some patients,” said Benjamin Krishna, co-author of the paper and a Cambridge university researcher....
...Her comments highlight difficulties in capitalising fully on the rising pace of scientific discoveries, boosted by artificial intelligence, as growing geopolitical tensions hinder international co-operation...
...US and European pharmaceutical manufacturers are concerned about supply shortages because a Chinese anti-espionage law is deterring them from sending inspectors to certify Chinese production facilities....
...Another official said: “What we want to do is give WHO a co-ordinating role but it should not mean that [data] cannot be shared through established systems. It is up to the member states.”...
...His efforts included a conversation with an unnamed “board member I knew at BI” and approaches to KKR co-founder Henry Kravis, its co-CEO Joseph Bae and Axel Springer’s Döpfner....
...A co-founder of activist fund ValueAct, Ubben said last year that his three-year-old Inclusive Capital was being wound down. He is also on the board of US oil major ExxonMobil....
International Edition